Who
Douglas Vincent Faller
Chief Medical Officer
Company insider
Files Form 4 as: Chief Medical Officer, Imunon.
In numbers
- Trades disclosed
- 20
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 18 Feb 2025
- Last trade
- 9 Oct 2026
- Last filed
- 13 Oct 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 9 Oct 2026filed 13 Oct 2026 | IMNN ImunonBiotechnology | SEC FORM 4 Code A | $1,3491,249 at $1.08 | filing |
| 25 Sep 2026filed 28 Sep 2026 | IMNN ImunonBiotechnology | SEC FORM 4 Code A | $6,1904,390 at $1.41 | filing |
| 25 Sep 2026filed 28 Sep 2026 | IMNN ImunonBiotechnology | SEC FORM 4 Code A | $6,1904,390 at $1.41 | filing |
| 11 Sep 2026filed 15 Sep 2026 | IMNN ImunonBiotechnology | SEC FORM 4 Code A | $6,1904,211 at $1.47 | filing |
| 11 Sep 2026filed 15 Sep 2026 | IMNN ImunonBiotechnology | SEC FORM 4 Code A | $6,1904,211 at $1.47 | filing |
| 28 Aug 2026filed 1 Sep 2026 | IMNN ImunonBiotechnology | SEC FORM 4 Code A | $5,8023,626 at $1.60 | filing |
| 28 Aug 2026filed 1 Sep 2026 | IMNN ImunonBiotechnology | SEC FORM 4 Code A | $5,8023,626 at $1.60 | filing |
| 14 Aug 2026filed 17 Aug 2026 | IMNN ImunonBiotechnology | SEC FORM 4 Code A | $5,8013,516 at $1.65 | filing |
| 14 Aug 2026filed 17 Aug 2026 | IMNN ImunonBiotechnology | SEC FORM 4 Code A | $5,8013,516 at $1.65 | filing |
| 31 Jul 2026filed 4 Aug 2026 | IMNN ImunonBiotechnology | SEC FORM 4 Code A | $5,8023,649 at $1.59 | filing |
| 31 Jul 2026filed 4 Aug 2026 | IMNN ImunonBiotechnology | SEC FORM 4 Code A | $5,8023,649 at $1.59 | filing |
| 17 Jul 2026filed 21 Jul 2026 | IMNN ImunonBiotechnology | SEC FORM 4 Code A | $5,6403,082 at $1.83 | filing |
| 17 Jul 2026filed 21 Jul 2026 | IMNN ImunonBiotechnology | SEC FORM 4 Code A | $5,6403,082 at $1.83 | filing |
| 2 Jul 2026filed 7 Jul 2026 | IMNN ImunonBiotechnology | SEC FORM 4 Code A | $2,4981,308 at $1.91 | filing |
| 2 Jul 2026filed 7 Jul 2026 | IMNN ImunonBiotechnology | SEC FORM 4 Code A | $2,4981,308 at $1.91 | filing |
| 25 Jun 2026filed 29 Jun 2026 | IMNN ImunonBiotechnology | SEC FORM 4 Code A | $38K21,896 at $1.72 | filing |
| 25 Jun 2026filed 29 Jun 2026 | IMNN ImunonBiotechnology | SEC FORM 4 Code A | $38K21,896 at $1.72 | filing |
| 2 Jan 2026filed 6 Jan 2026 | IMNN Imunonoption or derivative · Biotechnology | SEC FORM 4 Code A | —12,667 at $0.00 | filing |
| 2 Jan 2026filed 6 Jan 2026 | IMNN Imunonoption or derivative · Biotechnology | SEC FORM 4 Code A | —12,667 at $0.00 | filing |
| 18 Feb 2025filed 19 Feb 2025 | IMNN Imunonoption or derivative · Biotechnology | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.